Switching from Reta to Tirz for better inflammation and mast cell control

Thanks, though it is disappointing it quit working. Even tiny microdoses of Reta changed my appetite right away.

Thanks. The strange part for me is almost no weight has come off even though I still have fat to lose. I began Reta last fall and titrated slowly from 0.25 mg up to 2 mg. At the higher end I got anhedonia and dysesthesia so I backed down. With all my inflammatory symptoms I never know how I'll react. If other mast-cell patients find Tirz stronger for this, it's worth testing. Some have seen tryptase drop, and mine has stayed high for years even while on Reta.

I agree more people use Tirz, but I've also seen mast-cell patients specifically say they improved after leaving Reta. The glucagon part of Reta raises heart rate, which is a problem when you already have POTS or dysautonomia. ADHD adds another layer because anhedonia can appear. Side effects hit me at 2 mg so I tapered back. Appetite changed even at low doses, yet I wondered if ongoing inflammation was blocking weight loss. I tried to reach 2.5 mg but couldn't. Dropping to 1.5 mg then 1 mg improved mood and sensory issues. Yesterday I took my first 1 mg of Tirz and already notice easier breathing and lower pain, though the post cuts off there.

How did the 230-to-170 drop happen in six months? What dose, any lifting, meal pattern? Any details would be useful.

Another chronic-illness case here. I have the opposite CYP2D6 profile so many drugs are problematic. Responses really do vary. Reta cut food noise for me from the first 0.25 mg dose. No published microbiome data exists yet for Reta, but Tirz studies show increased butyrate producers, more Akkermansia that strengthens the gut barrier, fewer pathogens, and lower mTOR and NF-kB signaling. It may also calm mast cells through GLP-1 receptors and trigger autophagy that reduces excess mast cells.

I leaned hard on the appetite suppression and ate almost nothing until a small dinner. Ten thousand steps daily helped, though protein was low. It wasn't ideal but I was impatient. Using compounded product also pushed me to finish the supply faster.

Could the peptide source itself be contributing? I've seen reports of endotoxin-driven inflammation that appears without obvious cause.

Possible. The AI summaries attributed the rise to rapid loss alone, but that doesn't rule out an endotoxin contribution. I've used several other peptides so isolating one cause is difficult. Next labs in a couple months should clarify. Liver values were fine, at least.

Sounds like you've landed on what works; Tirz is the one for you. Other compounds can still be layered if inflammation remains the limiting factor.

To be frank, my tryptase readings hover in the thirties alongside this mix of overlapping issues like pots with dysautonomia, small fiber neuropathy, autoimmune autonomic neuropathy, fibromyalgia, adhd, ibs, me and cfs, mcas, possible mastocytosis, ongoing insomnia, and prior chronic migraines. Symptoms accumulate heavily. Top level doctor care still leaves gaps, and it bugs me when people dealing with pots or mcas describe glp-1 as fixing every problem, which leaves me questioning what sets my case apart. What stands out most is the lack of any weight drop so far, at least while using reta, which raises the possibility that body wide inflammation plays a role. Bpc looks like it targets the intestinal lining specifically while easing immune overdrive, and it hits both mtor and nf kb, which fits the picture. Kpv works through comparable routes to quiet those same overactive inflammatory signals. Maybe the adjustments so far fall short of fully dialing down the inflammation. An undetected clonal issue could hold those pathways open through tryptase signals, and the goal comes down to finding the right switches for restoring balance.

Good to hear. I'll stay with Tirz and watch how it goes. I expect I may handle it and higher doses better than Reta, where sides appeared at low amounts.

Your experience is encouraging. This week has been the best in a long time; Reta's gains carried over and Tirz added further improvement. Curious to see what happens with a possible dose increase from the current 1 mg. Case reports in MCAS noted even accidental higher doses were generally well tolerated.

Is Reta expected to lower inflammation?

Are calories being tracked? Sleep quality? Any new exercise? Those factors often drive both weight and inflammation.

Not sure it is supposed to, but I hoped the inflammation benefit seen with Tirz would carry over. Some accounts say Reta lowers markers, others say it does less or even increases joint pain. Lilly is running Phase 3 trials that include knee osteoarthritis pain, so results may clarify.

Looking forward to any updates; chronic pain is a daily issue for me too.

Calories are somewhat tracked and already lower than before. Exercise has increased lately because Tirz lets me walk farther without as much fatigue. Being only slightly overweight may change how the drug behaves compared with higher starting weights.

Reta's glucagon action raises metabolic rate and fat burning but also drives heart-rate increases. For my conditions Tirz has more user reports of inflammation relief. More receptor-interaction data would help explain the differences, but I haven't located studies yet.